Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged 18-65 years; (2) Virus nucleic acid test is positive; (3) Lung CT showed multiple patchy, lumpy ground glass opacity(GGO), consolidation or other typical manifestations in both lungs .
Exclusion criteria
Exclusion criteria: (1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus; (2) patients require mechanical ventilation; (3) People with metal or pacemaker; (4) active tuberculosis; (5) Massive pulmonary fibrosis; (6) Those with shock; (7) Those who have bleeding tendency or active bleeding in the lungs; (8) Patients with multiple organ failure who need ICU monitoring and treatment; (9) Patients with tumor and severe basic diseases; (10) pregnant or lactating women; (11) Patients with active tuberculosis; (12) Those with other contraindications to ultrashort wave; (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment; (14) Those without signed informed consent; (15) Researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the rate of Coronary virus nucleic acid negative at 7 days, 14 days, 21 days, and 28 days after Ultra Short Wave Electrotherapy;systemic inflammatory response syndrome (SIRS) scores at 7 days, 14 days, 21 days, and 28 days after Ultra Short Wave Electrotherapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| time to clinical recovey;the seven-category?ordinal scores at 7 days, 14 days, 21 days, and 28 days after Ultra Short Wave Electrotherapy; | — |
Countries
China
Contacts
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology